TITLE

Tracking the `fenphen' drug trend

PUB. DATE
September 1996
SOURCE
Physician & Sportsmedicine;Sep96, Vol. 24 Issue 9, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the popularity of the drugs fenfluramine and phentermine for weight reduction and appetite suppression. Mechanism by which both drugs promote weight loss; Prescription dosages of both drugs; Method by which physicians arrive at a decision to five the fenfluramine-phentermine combination to obese patients.
ACCESSION #
9701275875

 

Related Articles

  • Initial weight loss as a predictor of response to obesity drugs. Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L // International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333 

    BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients...

  • Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status. Whigham, L. D.; Dhurandhar, N. V.; Rahko, P. S.; Atkinson, R. L. // International Journal of Obesity;May2007, Vol. 31 Issue 5, p850 

    Background:Obesity treatment with single drugs produces weight losses of about 8–10% of initial body weight. Few studies of combinations of drugs for treating obesity have been published. The combination of phentermine, an adrenergic agent, and fenfluramine, a serotonergic agent,...

  • Fen-phen: Risky for dieters in any form.  // Consumer Reports;Sep97, Vol. 62 Issue 9, p6 

    Reports on the dangers of the diet drug fen-phen and its herbal counterpart, Herbal Fen-Phen. Where Herbal Fen-Phen is sold; Why the US Food and Drug Administration recommended against the use of fen-phen; Deaths related to the use of fen-phen.

  • Every New Mexico drugstore sued over phen-fen. Conlan, Michael F. // Drug Topics;12/7/98, Vol. 142 Issue 23, p24 

    Reports on the state lawsuit against 281 community pharmacies in New Mexico filed at the District Court in Santa Fe in 1998. Allegations of the plaintiffs regarding the manufacturers and sellers of fenfluramine-phentermine; Highlights of the case.

  • Phen-fen frenzy. Clive, Teagan // Joe Weider's Muscle & Fitness;Jan97, Vol. 58 Issue 1, p100 

    Focuses on the phentermine-fenfluramine (phen-fen) drug combination for weight loss. Effectiveness of the combination; Side effects; Disagreement between physicians on the drug combination; Background information on the phen-fen saga; Drug's potential for abuse. INSETS: Who gets phen-fen--and...

  • Demise of fen-phen a weighty issue for S.D. dieters. Acello, Richard // San Diego Business Journal;11/10/97, Vol. 18 Issue 45, p13 

    Reports that dieters who have taken `fen-phen,' a two-pill combination of fenfluramine and phentermine, were found to have leaky heart valves. Information on Weight Watchers' `1-2-3 Success' weight loss program; Goal of the program; Other weight loss programs; Key to successful weight loss.

  • New research aims to assess Redux/phen-fen controversy. Shaw, Kendall // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP23 

    Reports on the results of a study on the physiological effects of Redux or phentermine-fenfluramine intake. Average duration of Redux therapy; Rates of mild or greater aortic regurgitation; Mitral valve regurgitation; Cardiovascular symptoms; Aortic regurgitation.

  • GPs should join debate on potential risk versus reward of obesity drug. Castaneda, Reynald // New Zealand Doctor;10/8/2014, p14 

    The article focuses on the debate by general practitioners (GP) and clinicians in New Zealand on the risks and reward of the obesity drug phentermine.

  • Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causation. Hendricks, Ed J.; Rothman, Richard B.; Bryman, David A.; Schmidt, Stacy L. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2015, Vol. 55 Issue 2, p122 

    A letter to the editor is presented in response to the article "Subarachnoid Hemorrhage in a Patient Taking Phentermine for Weight Loss," by J. A. Brain, published in a 2014 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics